Logo-ipp

Original

1. The effect of interferon-β therapy on brain-derived neurotrophic factor serum concentration in relapsing— remitting multiple sclerosis: a randomized clinical trial
Nastaran Majdinasab ORCID, Mohammad Bahadoram ORCID, Syed Mohammad Taghi Mansouri, Shahram Tarahomi, Fatemeh Javanmardi ORCID, Habib Haybar
Immunopathol Persa. 2019;5(2): e14. doi: 10.15171/ipp.2019.14
Scopus ID: 85091670817    
Article
PDF
XML
Cited By:
2
0
Original

2. The prevalence of COVID-19 in patients with rheumatoid arthritis, multiple sclerosis, or systemic lupus erythematosus receiving biologic disease-modifying antirheumatic drugs
Arman Ahmadzadeh ORCID, Faraneh Farsad ORCID, Mohammad Mehdi Emam ORCID, Alireza Rajaei ORCID, Samaneh Hatami* ORCID, Latif Gachkar ORCID
Immunopathol Persa. 2021;7(2): e35. doi: 10.34172/ipp.2021.35
Scopus ID: 85112541938    
Article
PDF
XML
Cited By:
0
0
Original

3. Cannabis sativa L. oil extract affects neuroinflammation, clinical score, and cannabinoid receptor-1 gene expression in C57bl/6 experimental autoimmune encephalomyelitis
Iman Goraki ORCID, Mohammad Reza Shiri-Shahsavar ORCID, Mohammad Pourhassan-Moghaddam ORCID, Sharareh Khangaldi ORCID, Sina Khodakarimi ORCID, Mohammad Ebrahimi-kalan ORCID, Mohammad Jafar Maleki ORCID, Hanieh Beyrampour-Basmenj ORCID, Abbas Ebrahimi-kalan* ORCID
Immunopathol Persa. 2022;8(1): e4. doi: 10.34172/ipp.2022.04
Scopus ID: 85119209146    
Article
PDF
XML
Cited By:
2
3

Original

4. Exploring the therapeutic potential of Cerebrolysin-loaded exosomes in multiple sclerosis; an experimental study on neuroprotection and immune modulation
Mohammad Hassan Omrani ORCID, Sina Khodakarimi ORCID, Hanieh Beyrampour-Basmenj ORCID, Mahnaz Talebi ORCID, Naeimeh Akbari-Gharalari ORCID, Abbas Karimi ORCID, Zeynab Aliyari-Serej ORCID, Maryam Eyvazi ORCID, Ahmad Mehdipour ORCID, Abbas Ebrahimi-Kalan* ORCID
Immunopathol Persa. 2025;11(2): e41735. doi: 10.34172/ipp.2025.41735
Article
PDF
XML
Cited By:
0